Assessment of serum paraoxonase and arylesterase activity in patients with endometrial cancer

European Journal of Gynaecological Oncology

Volumn 30, Issue 6, 2009, Pages 679-682

  Arioz, D T ^a   Camuzcuoglu, H ^b   Toy, H ^b   Kurt, S ^c   Celik, H ^b   Erel, O ^b  

^a AFYON KOCATEPE UNIVERSITY   (Turkey)

^b HARRAN UNIVERSITY   (Turkey)

^c Aegean Maternity Hospital   (Turkey)

Author keywords

Arylesterase; Endometrial cancer; Lipid peroxidation; Paraoxonase

Indexed keywords

ARYLDIALKYLPHOSPHATASE; ARYLESTERASE; LIPID HYDROPEROXIDE;

ADULT; ARTICLE; BODY MASS; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOMETRIUM CANCER; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; HUMAN; MEDICAL ASSESSMENT;

ADULT; ARYLDIALKYLPHOSPHATASE; CARBOXYLIC ESTER HYDROLASES; CASE-CONTROL STUDIES; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; LIPID PEROXIDATION; MIDDLE AGED; SULFHYDRYL COMPOUNDS;

EID: 70949107027     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Murray T. et al.: "Cancer statistics, 2008". CA. Cancer. J. Clin., 2008, 58, 71.
2. Tall A.R.: "Plasma high density lipoproteins. Metabolism and relationship to atherogenesis". J. Clin. Invest., 1990, 86, 379.
3. Assmann G., Nofer J.R.: "Atheroprotective effects of high-density lipoproteins". Annu. Rev. Med., 2003, 54, 321.
4. Von Eckardstein A., Hersberger M., Rohrer L. "Current understanding of the metabolism and biological actions of HDL". Curr. Opin. Clin. Nutr. Metab. Care, 2005, 8, 147. (Pubitemid 40289474)
5. Mackness B., Mackness M.I., Arrol S., Turkie W., Julier K., Abuasha B. et al.: "Serum paraoxonase (PON 1) 55 and 192 polymorphism and paraoxonase activity and concentration in non-insulin dependent diabetes mellitus". Atherosclerosis, 1998, 139, 341. (Pubitemid 28361819)
6. Mackness B., Durrington P.N., Mackness M.I.: "Human serum paraoxonase". Gen. Pharmacol., 1998, 31, 329.
7. Durrington P.N., Mackness B., Mackness M.I.: "Paraoxonase and atherosclerosis". Arterioscler. Thromb. Vasc. Biol., 2001, 21, 473.
8. Canales A., Sánchez-Muniz F.J.: "Paraoxonase, something more than an enzyme?". Med. Clin. (Barc), 2003, 121, 537. (Pubitemid 37429019)
9. Aviram M., Rosenblat M.: "Paraoxonases 1, 2, and 3, oxidative stress, and macrophage foam cell formation during atherosclerosis development". Free. Radic. Biol. Med., 2004, 37, 1304. (Pubitemid 39349234)
10. Ng C.J., Shih D.M., Hama S.Y., Villa N., Navab M., Reddy S.T. "The paraoxonase gene family and atherosclerosis". Free. Radic. Biol. Med., 2005, 38, 153.
11. Aviram M., Rosenblat M., Billecke S., Erogul J., Sorenson R., Bisgaier C.L. et al.: "Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants". Free. Radic. Biol. Med., 1999, 26, 892. (Pubitemid 29198362)
12. Aslan M., Kosecik M., Horoz M., Selek S., Celik H., Erel O.: "Assessment of paraoxonase and arylesterase activities in patients with iron deficiency anemia". Atherosclerosis, 2007, 191, 397. (Pubitemid 46400702)
13. Selek S., Cosar N., Kocyigit A., Erel O., Aksoy N., Gencer M. et al.: "PON1 activity and total oxidant status in patients with active pulmonary tuberculosis". Clin. Biochem., 2008, 41, 140.
14. Akçay M.N., Yilmaz I., Polat M.F., Akçay G.: "Serum paraoxonase levels in gastric cancer". Hepatogastroenterology, 2003, 50, 273.
15. Akçay M.N., Polat M.F., Yilmaz I., Akçay G.: "Serum paraoxonase levels in pancreatic cancer". Hepatogastroenterology, 2003, 50, 225.
16. Elkiran E.T., Mar N., Aygen B., Gursu F., Karaoglu A., Koca S.: "Serum paraoxonase and arylesterase activities in patients with lung cancer in a Turkish population". BMC Cancer, 2007, 7, 48. (Pubitemid 46510374)
17. Eckerson H.W., Wyte C.M., La Du B.N.: "The human serum paraoxonase/arylesterase polymorphism". Am. J. Hum. Genet., 1983, 35, 1126.
18. Nourooz-Zadeh J.: "Ferrous ion oxidation in presence of xylenol orange for detection of lipid hydroperoxides in plasma". Methods Enzymol., 1999, 300, 58.
19. Erel O.: "A novel automated method to measure total antioxidant response against potent free radical reactions". Clin. Biochem., 2004, 37, 112.
20. Loft S., Poulsen H.E.: "Cancer risk and oxidative DNA damage in man". J. Mol. Med., 1996, 74, 297. (Pubitemid 26195901)
21. Valko M., Leibfritz D., Moncol J., Cronin M.T., Mazur M., Telser J.: "Free radicals and antioxidants in normal physiological functions and human disease". Int. J. Biochem. Cell. Biol., 2007, 39, 44. (Pubitemid 44566469)
22. Goldstein B.D., Witz G.: "Free radicals and carcinogenesis". Free. Radic. Res. Commun., 1990, 11, 3.
23. Kaynar H., Meral M., Turhan H., Keles M., Celik G., Akcay F.: "Glutathione peroxidase, glutathione-S-transferase, catalase, xanthine oxidase, Cu-Zn superoxide dismutase activities, total glutathione, nitric oxide, and malondialdehyde levels in erythrocytes of patients with small cell and non-small cell lung cancer". Cancer Lett., 2005, 227, 133. (Pubitemid 41169926)
24. Gonenc A., Ozkan Y., Torun M., Simsek B.: "Plasma malondialdehyde (MDA) levels in breast and lung cancer patients". J. Clin. Pharm. Ther., 2001, 26, 141. (Pubitemid 32336730)
25. Punnonen R., Kudo R., Punnonen K., Hietanen E., Kuoppala T., Kainulainen H. et al.: "Activities of antioxidant enzymes and lipid peroxidation in endometrial cancer". Eur. J. Cancer, 1993, 29, 266.
26. Manoharan S., Kolanjiappan K., Kayalvizhi M.: "Enhanced lipid peroxidation and impaired enzymic antioxidant activities in the erythrocytes of patients with cervical carcinoma". Cell. Mol. Biol. Lett., 2004, 9, 699. (Pubitemid 40065195)
27. Pejić S, Kasapović J., Todorović A., Stojiljković V., Pajović S.B.: "Lipid peroxidation and antioxidant status in blood of patients with uterine myoma, endometrial polypus, hyperplastic and malignant endometrium". Biol. Res., 2006, 39, 619.
28. Camuzcuoglu H., Arioz D.T., Toy H., Kurt S., Celik H., Erel O.: "Serum paraoxonase and arylesterase activities in patients with epithelial ovarian cancer". Gynecol. Oncol., 2009, 112, 481.